BG Medicine Probability of Future Pink Sheet Price Finishing Over 0.046

BGMDDelisted Stock  USD 0.0002  0.00  0.00%   
BG Medicine's future price is the expected price of BG Medicine instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of BG Medicine performance during a given time horizon utilizing its historical volatility. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.
  
Please specify BG Medicine's target price for which you would like BG Medicine odds to be computed.

BG Medicine Target Price Odds to finish over 0.046

The tendency of BGMD Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move over $ 0.05  or more in 90 days
 0.0002 90 days 0.05 
close to zero percent
Based on a normal probability distribution, the odds of BG Medicine to move over $ 0.05  or more in 90 days from now is close to zero percent (This BG Medicine probability density function shows the probability of BGMD Pink Sheet to fall within a particular range of prices over 90 days) . Probability of BG Medicine price to stay between its current price of $ 0.0002  and $ 0.05  at the end of the 90-day period is about 57.48 .
Given the investment horizon of 90 days BG Medicine has a beta of -6.21 suggesting as returns on its benchmark rise, returns on holding BG Medicine are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, BG Medicine is expected to outperform its benchmark. In addition to that BG Medicine has an alpha of 5.6963, implying that it can generate a 5.7 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
   BG Medicine Price Density   
       Price  

Predictive Modules for BG Medicine

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as BG Medicine. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of BG Medicine's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.000.00030.00
Details
Intrinsic
Valuation
LowRealHigh
0.000.00020.00
Details
Naive
Forecast
LowNextHigh
0.00020.00020.0002
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.00020.00020.0002
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as BG Medicine. Your research has to be compared to or analyzed against BG Medicine's peers to derive any actionable benefits. When done correctly, BG Medicine's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in BG Medicine.

BG Medicine Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. BG Medicine is not an exception. The market had few large corrections towards the BG Medicine's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold BG Medicine, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of BG Medicine within the framework of very fundamental risk indicators.
α
Alpha over NYSE Composite
5.70
β
Beta against NYSE Composite-6.21
σ
Overall volatility
0.0001
Ir
Information ratio 0.15

BG Medicine Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of BG Medicine for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for BG Medicine can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
BG Medicine is not yet fully synchronised with the market data
BG Medicine has some characteristics of a very speculative penny stock
BG Medicine has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 1.57 M. Net Loss for the year was (5.3 M) with profit before overhead, payroll, taxes, and interest of 1.06 M.
BG Medicine currently holds about 1.52 M in cash with (3.67 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.14, which can makes it an attractive takeover target, given it will continue generating positive cash flow.

BG Medicine Technical Analysis

BG Medicine's future price can be derived by breaking down and analyzing its technical indicators over time. BGMD Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of BG Medicine. In general, you should focus on analyzing BGMD Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.

BG Medicine Predictive Forecast Models

BG Medicine's time-series forecasting models is one of many BG Medicine's pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary BG Medicine's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.

Things to note about BG Medicine

Checking the ongoing alerts about BG Medicine for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for BG Medicine help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
BG Medicine is not yet fully synchronised with the market data
BG Medicine has some characteristics of a very speculative penny stock
BG Medicine has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 1.57 M. Net Loss for the year was (5.3 M) with profit before overhead, payroll, taxes, and interest of 1.06 M.
BG Medicine currently holds about 1.52 M in cash with (3.67 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.14, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.
You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Consideration for investing in BGMD Pink Sheet

If you are still planning to invest in BG Medicine check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BG Medicine's history and understand the potential risks before investing.
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Global Correlations
Find global opportunities by holding instruments from different markets
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities